The Cholesterol Conundrum: Why a New Test May Be Just What the Doctor Ordered The medical community has long relied on measuring low density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol, to gauge cardiovascular risk.
However, new research from Northwestern University suggests that this approach may be inadequate and that another test – apoB – could provide a more accurate indicator of cardiovascular risk.
ApoB measures the total number of harmful particles in the blood, giving doctors a more direct indication of patients' cardiovascular risk than standard LDL testing.